Ukrain in the treatment of urethral recurrent carcinoma (case report).
In a patient with low grade differentiated urethral carcinoma (histologically: urothelial carcinoma G2 and G3, pT1 with low grade differentiation) operation was carried out, with recurrence after two months. Instead of reoperation the patient was given Ukrain as monotherapy. No carcinoma was detected four months later by histological examination or during examinations three years later.
Kadan
P
P
Ukrainian Anti-Cancer Institute, Vienna, Austria.
Korsh
O B
OB
Hiesmayr
W
W
D000470:Alkaloids / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001600:Berberine Alkaloids; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000601:surgery; D010617:Phenanthridines; D014523:Urethral Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000470:Alkaloids; D000970:Antineoplastic Agents; D001600:Berberine Alkaloids; D010617:Phenanthridines; C060921:ukrain